The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine

Documenti analoghi

• Reply to “A Comment about AI Methods that May Help Advance Pharmacovigilance”
  di: Charles Khouri, et al.
  Pubblicazione: (2026)
• FDA Adverse Event Reporting System Essentials: A Reflection on Study Conception
  di: Emanuel Raschi, et al.
  Pubblicazione: (2025)
• Chat GPT and the Challenges to Detect Potential Drug–Drug Interactions Related to QT Prolongation
  di: Emanuel Raschi, et al.
  Pubblicazione: (2025)
• Respiratory Disorders Associated with Antibody–Drug Conjugates: A Combined Analysis of the French and the WHO Pharmacovigilance Databases
  di: Victor Mirleau, et al.
  Pubblicazione: (2025)
• Misuse of the Term Biorhythms Undermines Chronobiological Research
  di: Yvan Touitou
  Pubblicazione: (2025)